サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：医療対策市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2023年～2030年）- 製品別、用途別、地域別（北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ）
市場調査レポート
商品コード
1312416

医療対策市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2023年～2030年）- 製品別、用途別、地域別（北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ）

Medical Countermeasures Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

出版日
ページ情報
英文 220 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医療対策市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2023年～2030年）- 製品別、用途別、地域別（北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ）
出版日: 2023年07月17日
発行: Fairfield Market Research
ページ情報: 英文 220 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の医療対策の市場規模は、不確実なアウトブレイクに対抗するための、入手しやすく効果的な医薬品に対する需要の高まりに後押しされ、ヘルスケア産業において大きな躍進を遂げています。ヘルスケア従事者の努力を維持し、疾病の蔓延を防止するための強固で的確な医療対策が必要とされる中、市場は医薬品の安全性保証において著しい成長に向けて前進しています。

当レポートでは、世界の医療対策市場について調査し、市場の概要とともに、タイプ別、製品別、用途別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 規制の枠組み
  • 政府の取り組みと投資
  • 技術の進歩
  • PESTLE分析
  • バリューチェーン分析
  • COVID-19の影響分析

第3章 世界の医療対策市場の見通し、2018年～2030年

  • 世界の医療対策市場の見通し、タイプ別、2018年～2030年
  • 世界の医療対策市場の見通し、製品別、2018年～2030年
  • 世界の医療対策市場の見通し、用途別、2018年～2030年
  • 世界の医療対策市場の見通し、地域別、2018年～2030年

第4章 北米の医療対策市場の見通し、2018年～2030年

第5章 欧州の医療対策市場の見通し、2018年～2030年

第6章 アジア太平洋の医療対策市場の見通し、2018年～2030年

第7章 ラテンアメリカの医療対策市場の見通し、2018年～2030年

第8章 中東・アフリカの医療対策市場の見通し、2018年～2030年

第9章 競合情勢

  • 市場シェア分析
  • 企業プロファイル
    • Pfizer, Inc.
    • Altimmune, Inc.
    • SIGA Technologies
    • Bavarian Nordic A/S
    • Dynavax Technologies Corporation
    • National Resilience, Inc.
    • GSK plc
    • Xoma Corporation
    • Meridian Medical Technologies, LLC
    • Bruker Detection
    • Ichor Medical Systems
    • Teledyne Technologies, Inc.
    • その他

第10章 付録

目次

The global medical countermeasures market is experiencing a major breakthrough in the healthcare industry, driven by the increasing demand for accessible and effective medicines to combat uncertain outbreaks. With the need for robust and apt medical countermeasures to sustain the efforts of healthcare workers and prevent the spread of diseases, the market is advancing towards significant growth in the safety assurance of drugs.

Growing Demand for Medical Countermeasures in the Face of Uncertain Outbreaks

Healthcare providers are increasingly relying on medical countermeasures to address the uncertainty of outbreaks and ensure accessible medicines with fewer side effects upon successful diagnosis. The availability of extensive vaccines or antivirals that are unapproved can lead to ineffective treatments, undermining efforts to produce safe and effective drugs. To maintain consistent efforts in healthcare and prevent diseases from spreading, the demand for robust and suitable medical countermeasures has risen incessantly.

Rigorous Quality Checks and Clinical Trials Enhance Market Potential

Before entering the market, drugs undergo rigorous quality checks and clinical trials to ensure their safety and efficacy. Government agencies like the U.S. Food and Drug Administration (FDA) pre-evaluate medications sold in the market, further assuring safety to consumers. These stringent quality checks, coupled with growing awareness of medical countermeasures and unpredictable outbreaks, are expected to expand the dimensions of the medical countermeasures market and boost sales in the coming years.

Rising Prevalence of Infectious Diseases and Advancements in Precision Medicines Propel Market Growth

The medical countermeasures market, comprising medical devices and therapeutic products, is dominated by vaccines, particularly due to the prevalence of infectious diseases like HIV/AIDS. The market is witnessing continuous growth as an increasing number of patients require life-saving vaccines to combat lethal diseases such as dengue and influenza virus (H1N1). Advancements in personalized medicine and Matrix Metalloproteinases (MMPs) are also expected to drive market expansion. Additionally, rising awareness about countermeasures to combat biological agents further boosts the momentum for the medical countermeasures market.

Asia Pacific Emerges as a Promising Market with Robust Investments in Research & Development

While the U.S. leads the global medical countermeasures market with strict norms and regulations on drug development and rising awareness about bioterrorism attacks, Asia Pacific is poised to demonstrate substantial growth during the forecast period. The region's market is influenced by increasing biological warfare threats and growing investments in research and development by key players to develop countermeasures against bio aggressors. Moreover, the region's sophisticated infrastructure and government investments in the latest countermeasures and R&D contribute to market growth.

Leading Players Shaping the Global Medical Countermeasures Market

Some of the prominent players operating in the global medical countermeasures market include: Sanofi Pasteur, Johnson & Johnson, CSL Limited, GlaxoSmithKline plc, Pfizer, Inc., Emergent BioSolutions, Inc., Daiichi Sankyo Company, Limited, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd., Merck & Co., Inc., Bavarian Nordic, AstraZeneca, Bharat Biotech, Incepta Vaccine Ltd., Biological E, Sinovac Biotech Ltd., Valneva SE, PT Bio Farma, Panacea Biotec, and VBI Vaccines Inc.

Table of Contents

1. Executive Summary

  • 1.1. Global Medical Countermeasures Market Outlook, 2018 - 2030 (US$ Million)
  • 1.2. Global Medical Countermeasures Market Incremental Opportunity, 2018 - 2030 (US$ Million)
  • 1.3. Key Industry Trends

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
      • 2.2.1.1. Driver 1
      • 2.2.1.2. Driver 2
    • 2.2.2. Restraints
      • 2.2.2.1. Restraint 1
      • 2.2.2.2. Restraint 2
    • 2.2.3. Opportunities
      • 2.2.3.1. Opportunity 1
      • 2.2.3.2. Opportunity 2
  • 2.3. Regulatory Framework
  • 2.4. Government Initiatives and Investments
  • 2.5. Technological Advancements
  • 2.6. PESTLE Analysis
  • 2.7. Value Chain Analysis
  • 2.8. COVID-19 Impact Analysis

3. Global Medical Countermeasures Market Outlook, 2018 - 2030

  • 3.1. Global Medical Countermeasures Market Outlook, by Type, 2018 - 2030
    • 3.1.1. Key Highlights
    • 3.1.2. Global Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 3.1.2.1. Drugs
      • 3.1.2.2. Biologics
      • 3.1.2.3. Devices
    • 3.1.3. Global Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
    • 3.1.4. Global Medical Countermeasures Market Attractiveness Analysis, by Type, 2023 - 2030
  • 3.2. Global Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 3.2.1. Key Highlights
    • 3.2.2. Global Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 3.2.2.1. Diagnostic
      • 3.2.2.2. Therapeutic
      • 3.2.2.3. Prophylactic
    • 3.2.3. Global Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
    • 3.2.4. Global Medical Countermeasures Market Attractiveness Analysis, By Product, 2023 - 2030
  • 3.3. Global Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 3.3.1. Key Highlights
    • 3.3.2. Global Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 3.3.2.1. Small pox
      • 3.3.2.2. Anthrax
      • 3.3.2.3. Botulism
      • 3.3.2.4. Chemical Threat
      • 3.3.2.5. Radiological/Nuclear Threat
      • 3.3.2.6. Emerging Infectious Diseases
      • 3.3.2.7. Others
    • 3.3.3. Global Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
    • 3.3.4. Global Medical Countermeasures Market Attractiveness Analysis, by Application, 2023 - 2030
  • 3.4. Global Medical Countermeasures Market Outlook, By Region, 2018 - 2030
    • 3.4.1. Key Highlights
    • 3.4.2. Global Medical Countermeasures Market Outlook, by Region, Value (US$ Million), 2018 - 2030
      • 3.4.2.1. North America
      • 3.4.2.2. Europe
      • 3.4.2.3. Asia Pacific
      • 3.4.2.4. Latin America
      • 3.4.2.5. Middle East & Africa
    • 3.4.3. Global Medical Countermeasures Market Share and BPS Analysis, by Region, 2023 and 2030
    • 3.4.4. Global Medical Countermeasures Market Attractiveness Analysis, by Region, 2023 - 2030

4. North America Medical Countermeasures Market Outlook, 2018 - 2030

  • 4.1. North America Medical Countermeasures Market Outlook, by Type, 2018 - 2030
    • 4.1.1. Key Highlights
    • 4.1.2. North America Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 4.1.2.1. Drugs
      • 4.1.2.2. Biologics
      • 4.1.2.3. Devices
    • 4.1.3. North America Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
  • 4.2. North America Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 4.2.1. Key Highlights
    • 4.2.2. North America Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 4.2.2.1. Diagnostic
      • 4.2.2.2. Therapeutic
      • 4.2.2.3. Prophylactic
    • 4.2.3. North America Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
  • 4.3. North America Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 4.3.1. Key Highlights
    • 4.3.2. North America Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 4.3.2.1. Small pox
      • 4.3.2.2. Anthrax
      • 4.3.2.3. Botulism
      • 4.3.2.4. Chemical Threat
      • 4.3.2.5. Radiological/ Nuclear Threat
      • 4.3.2.6. Emerging Infectious Diseases
      • 4.3.2.7. Others
    • 4.3.3. North America Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
  • 4.4. North America Medical Countermeasures Market Outlook, By Country, 2018 - 2030
    • 4.4.1. Key Highlights
    • 4.4.2. North America Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 4.4.2.1. U.S.
      • 4.4.2.2. Canada
    • 4.4.3. North America Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

5. Europe Medical Countermeasures Market Outlook, 2018 - 2030

  • 5.1. Europe Medical Countermeasures Market Outlook, by Type, 2018 - 2030
    • 5.1.1. Key Highlights
    • 5.1.2. Europe Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 5.1.2.1. Drugs
      • 5.1.2.2. Biologics
      • 5.1.2.3. Devices
    • 5.1.3. Europe Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
  • 5.2. Europe Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 5.2.1. Key Highlights
    • 5.2.2. Europe Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 5.2.2.1. Diagnostic
      • 5.2.2.2. Therapeutic
      • 5.2.2.3. Prophylactic
    • 5.3.3. Europe Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
  • 5.3. Europe Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 5.3.1. Key Highlights
    • 5.3.2. Europe Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 5.3.2.1. Small pox
      • 5.3.2.2. Anthrax
      • 5.3.2.3. Botulism
      • 5.3.2.4. Chemical Threat
      • 5.3.2.5. Radiological/Nuclear Threat
      • 5.3.2.6. Emerging Infectious Diseases
      • 5.3.2.7. Others
    • 5.3.3. Europe Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
  • 5.4. Europe Medical Countermeasures Market Outlook, By Country, 2018 - 2030
    • 5.4.1. Key Highlights
    • 5.4.2. Europe Medical Countermeasures Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 5.4.2.1. Germany
      • 5.4.2.2. France
      • 5.4.2.3. U.K.
      • 5.4.2.4. Italy
      • 5.4.2.5. Spain
      • 5.4.2.6. Russia
      • 5.4.2.7. Rest of Europe
    • 5.4.3. Europe Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

6. Asia Pacific Medical Countermeasures Market Outlook, 2018 - 2030

  • 6.1. Asia Pacific Medical Countermeasures Market Outlook, by Type, 2018 - 2030
    • 6.1.1. Key Highlights
    • 6.1.2. Asia Pacific Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 6.1.2.1. Drugs
      • 6.1.2.2. Biologics
      • 6.1.2.3. Devices
    • 6.1.3. Asia Pacific Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
  • 6.2. Asia Pacific Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 6.2.1. Key Highlights
    • 6.2.2. Asia Pacific Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 6.2.2.1. Diagnostic
      • 6.2.2.2. Therapeutic
      • 6.2.2.3. Prophylactic
    • 6.2.3. Asia Pacific Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
  • 6.3. Asia Pacific Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 6.3.1. Key Highlights
    • 6.3.2. Asia Pacific Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 6.3.2.1. Small pox
      • 6.3.2.2. Anthrax
      • 6.3.2.3. Botulism
      • 6.3.2.4. Chemical Threat
      • 6.3.2.5. Radiological/Nuclear Threat
      • 6.3.2.6. Emerging Infectious Diseases
      • 6.3.2.7. Others
    • 6.3.3. Asia Pacific Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
  • 6.4. Asia Pacific Medical Countermeasures Market Outlook, By Country, 2018 - 2030
    • 6.4.1. Key Highlights
    • 6.4.2. Asia Pacific Medical Countermeasures Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 6.4.2.1. Japan
      • 6.4.2.2. China
      • 6.4.2.3. India
      • 6.4.2.4. Australia & New Zealand
      • 6.4.2.5. South Korea
      • 6.4.2.6. Rest of Asia Pacific
    • 6.4.3. Asia Pacific Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

7. Latin America Medical Countermeasures Market Outlook, 2018 - 2030

  • 7.1. Latin America Medical Countermeasures Market Outlook, by Type, 2018 - 2030
    • 7.1.1. Key Highlights
    • 7.1.2. Latin America Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 7.1.2.1. Drugs
      • 7.1.2.2. Biologics
      • 7.1.2.3. Devices
    • 7.1.3. Latin America Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
  • 7.2. Latin America Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 7.2.1. Key Highlights
    • 7.2.2. Latin America Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 7.2.2.1. Diagnostic
      • 7.2.2.2. Therapeutic
      • 7.2.2.3. Prophylactic
    • 7.2.3. Latin America Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
  • 7.3. Latin America Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 7.3.1. Key Highlights
    • 7.3.2. Latin America Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 7.3.2.1. Small pox
      • 7.3.2.2. Anthrax
      • 7.3.2.3. Botulism
      • 7.3.2.4. Chemical Threat
      • 7.3.2.5. Radiological/Nuclear Threat
      • 7.3.2.6. Emerging Infectious Diseases
      • 7.3.2.7. Others
    • 7.3.3. Latin America Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
  • 7.4. Latin America Medical Countermeasures Market Outlook, By Country, 2018 - 2030
    • 7.4.1. Key Highlights
    • 7.4.2. Latin America Medical Countermeasures Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 7.4.2.1. Brazil
      • 7.4.2.2. Mexico
      • 7.4.2.3. Argentina
      • 7.4.2.4. Rest of Latin America
    • 7.4.3. Latin America Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

8. Middle East & Africa Medical Countermeasures Market Outlook, 2018 - 2030

  • 8.1. Middle East & Africa Medical Countermeasures Market Outlook, Type, 2018 - 2030
    • 8.1.1. Key Highlights
    • 8.1.2. Middle East & Africa Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 8.1.2.1. Drugs
      • 8.1.2.2. Biologics
      • 8.1.2.3. Devices
    • 8.1.3. Middle East & Africa Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
  • 8.2. Middle East & Africa Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 8.2.1. Key Highlights
    • 8.2.2. Middle East & Africa Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 8.2.2.1. Diagnostic
      • 8.2.2.2. Therapeutic
      • 8.2.2.3. Prophylactic
    • 8.2.3. Middle East & Africa Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
  • 8.3. Middle East & Africa Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 8.3.1. Key Highlights
    • 8.3.2. Middle East & Africa Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 8.3.2.1. Small pox
      • 8.3.2.2. Anthrax
      • 8.3.2.3. Botulism
      • 8.3.2.4. Chemical Threat
      • 8.3.2.5. Radiological/Nuclear Threat
      • 8.3.2.6. Emerging Infectious Diseases
      • 8.3.2.7. Others
    • 8.3.3. Middle East & Africa Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
  • 8.4. Middle East & Africa Medical Countermeasures Market Outlook, By Country, 2018 - 2030
    • 8.4.1. Key Highlights
    • 8.4.2. Middle East & Africa Medical Countermeasures Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 8.4.2.1. Saudi Arabia
      • 8.4.2.2. UAE
      • 8.4.2.3. South Africa
      • 8.4.2.4. Rest of Middle East & Africa
    • 8.4.3. Middle East & Africa Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

9. Competitive Landscape

  • 9.1. Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1. Pfizer, Inc.
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product Portfolio
      • 9.2.1.4. Recent Developments
    • 9.2.2. Altimmune, Inc.
    • 9.2.3. SIGA Technologies
    • 9.2.4. Bavarian Nordic A/S
    • 9.2.5. Dynavax Technologies Corporation
    • 9.2.6. National Resilience, Inc.
    • 9.2.7. GSK plc
    • 9.2.8. Xoma Corporation
    • 9.2.9. Meridian Medical Technologies, LLC
    • 9.2.10. Bruker Detection
    • 9.2.11. Ichor Medical Systems
    • 9.2.12. Teledyne Technologies, Inc.
    • 9.2.13. Others

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Specific Research Approach
  • 10.3. Acronyms and Abbreviations